Breast Cancer Profiling Project, Drug Sensitivity phase II: Fixed-cell GR measures of 33 breast cell lines and PDX lines to 16 small molecule perturbagens from library plate II. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20354)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Mean Normalized Growth Rate Inhibition Value | Increased Fraction Dead |
|---|---|---|---|---|
| MDA-MB-134-VI | Alvocidib | 0.0316227766017 | 0.7346 | -0.03137 |
| MDA-MB-134-VI | Alvocidib | 0.1 | 0.5963 | -0.02043 |
| MDA-MB-134-VI | Alvocidib | 0.1 | 0.9254 | -0.02309 |
| MDA-MB-134-VI | Alvocidib | 0.1 | 1.0138 | -0.02210 |
| MDA-MB-134-VI | Alvocidib | 0.316227766017 | 0.1181 | 0.00003 |
| MDA-MB-134-VI | Alvocidib | 0.316227766017 | 0.0735 | -0.00252 |
| HCC1500 | Alvocidib | 0.316227766017 | 0.64032 | |
| MDA-MB-134-VI | Alvocidib | 0.316227766017 | 0.91225 | |
| MDA-MB-134-VI | Alvocidib | 1.0 | -0.4364 | 0.16005 |
| MDA-MB-134-VI | Alvocidib | 1.0 | -0.4621 | 0.16926 |
| MDA-MB-134-VI | Alvocidib | 1.0 | -0.2986 | 0.16306 |
| HCC1500 | Alvocidib | 0.1 | 0.5333 | -0.13181 |
| HCC1500 | Alvocidib | 0.1 | -0.5415 | -0.17913 |